Nuwellis (NUWE) Shareholder's Equity Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.54% |
| Dec 31, 2025 | -30.62% |
| Sep 30, 2025 | -28.09% |
| Jun 30, 2025 | -24.01% |
| Mar 31, 2025 | -14.22% |
| Dec 31, 2024 | 26.82% |
| Sep 30, 2024 | -6.04% |
| Jun 30, 2024 | -22.96% |
| Mar 31, 2024 | -41.14% |
| Dec 31, 2023 | -12.82% |
| Sep 30, 2023 | -4.08% |
| Jun 30, 2023 | 4.68% |
| Mar 31, 2023 | 1.98% |
| Dec 31, 2022 | -5.32% |
| Sep 30, 2022 | 14.96% |
| Jun 30, 2022 | 13.20% |
| Mar 31, 2022 | 41.32% |
| Dec 31, 2021 | 71.34% |
| Sep 30, 2021 | 64.89% |
| Jun 30, 2021 | 47.77% |
| Mar 31, 2021 | 31.87% |
| Dec 31, 2020 | 6.04% |
| Sep 30, 2020 | 1.97% |
| Jun 30, 2020 | -17.10% |
| Mar 31, 2020 | -23.84% |
| Dec 31, 2019 | -41.57% |
| Sep 30, 2019 | -34.16% |
| Jun 30, 2019 | -26.94% |
| Mar 31, 2019 | -22.98% |
| Dec 31, 2018 | -35.14% |
| Sep 30, 2018 | -30.10% |
| Jun 30, 2018 | -15.45% |
| Mar 31, 2018 | 4.58% |
| Dec 31, 2017 | 4.63% |
| Sep 30, 2017 | -15.64% |
| Jun 30, 2017 | 71.27% |
| Mar 31, 2017 | 5.49% |
| Dec 31, 2016 | -17.50% |